Website & contact details
- Group website
- The site of this company’s group or brand.
Lyra Health International Limited
- Incorporated
- 4 September 1996 (30 years)
- Previously known as
- Icas International Holdings Limited (until 17 November 2023)Icas Group Limited (until 9 January 2004)
- Industry
- Other human health activities (86900)
- Directors
- Lisa Caccavo
- Accounts type
- Full
- Region
- Greater London
- Address
- 85 Gresham StreetLondonEC2V 7NQ
Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 17 June 2027
- Last conf. stmt
- 3 June 2026
Charges
- Total
- 5
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 5
Officers 2 active
Officer details are public data from the Companies House register.
Caccavo, Lisa
Director · Appointed 23 December 2021
American
Born February 1976 (50)
Director · Appointed 12 October 2007
South African
Born August 1966 (60)
Officer history (43 former)
2 May 2025
23 December 2021
23 December 2021
Appointed Caccavo, Lisa as Director
23 December 2021
23 December 2021
23 December 2021
23 December 2021
17 March 2021
17 March 2021
11 February 2021
20 March 2020
20 March 2020
20 March 2020
19 March 2020
19 March 2020
19 March 2020
19 March 2020
19 March 2020
19 March 2020
Resigned Parkinson, Glen as Director
19 March 2020
31 March 2019
12 February 2019
31 December 2018
9 April 2018
15 June 2017
4 May 2017
27 January 2017
15 November 2016
15 November 2016
31 October 2016
27 June 2016
29 March 2016
19 November 2015
Appointed Parkinson, Glen as Director
26 October 2015
1 October 2015
12 November 2014
12 November 2014
23 October 2014
31 August 2014
3 March 2014
28 February 2014
29 July 2013
17 July 2013
Resigned Edwards, Andrew Charles as Director
12 October 2011
Resigned Simpson, John Mark Wallace, Dr as Director
24 June 2011
16 September 2010
6 August 2010
14 April 2010
10 March 2010
Resigned Garman, Jeremy David as Director
31 January 2010
Resigned Mccaw, Elizabeth Ann as Director
21 January 2010
31 October 2009
Resigned Reddy, Michael Joseph, Dr as Director
28 October 2009
17 June 2009
1 May 2009
29 February 2008
Appointed Simpson, John Mark Wallace, Dr as Director
29 February 2008
Appointed Garman, Jeremy David as Director
29 February 2008
Appointed Mccaw, Elizabeth Ann as Director
29 February 2008
Appointed Edwards, Andrew Charles as Director
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
12 October 2007
19 September 2006
14 September 2005
1 November 2003
30 October 2003
Resigned Tooman, Joseph Michael as Director
31 May 2003
30 June 2001
29 June 2001
Resigned Freeman, Kenneth as Director
29 June 2001
Resigned Freeman, Kenneth as Secretary
1 May 1997
Appointed Freeman, Kenneth as Director
24 December 1996
30 September 1996
Appointed Tooman, Joseph Michael as Director
30 September 1996
30 September 1996
4 September 1996
4 September 1996
4 September 1996
4 September 1996
4 September 1996
Appointed Freeman, Kenneth as Secretary
4 September 1996
Appointed Reddy, Michael Joseph, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 16 March 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 13065199
Former controllers (2)
16 March 2021
Ceased Rox Equity Partners Limited — Owns 75–100% of shares
19 March 2020
Ceased Axa PPP Healthcare Group Limited — Owns 75–100% of shares
Group structure 4 companies
Ownership group derived from the Companies House PSC register
Lyra Health International Limited This company Owns 75–100% of shares
Lyra International Tech Limited Owns 75–100% of shares
Lyra UK & Ireland Limited Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2024 · full accounts
- Net Assets
- £77,000
- Cash
- £981,000
- Turnover
- £25,854,000
- Profit Before Tax
- (£3,662,000)
- Employees
- 80
- Debt Ratio
- 100%
- Current Ratio
- 0.8x
- Profit Margin
- -14%
- Return on Equity
- -4657%
Trend
Turnover
Balance sheet detail
| 2024 | 2022 | 2021 | |
|---|---|---|---|
| Fixed Assets | £3,685,000 | £3,865,000 | £3,864,000 |
| Current Assets | £17,438,000 | £11,256,000 | £8,919,000 |
| Cash | £981,000 | £2,309,000 | £2,312,000 |
| Creditors (< 1 year) | £21,046,000 | £6,274,000 | £4,501,000 |
| Net Current Assets | (£3,608,000) | ||
| Net Assets | £77,000 | £8,847,000 | £8,283,000 |
| Shareholder Funds | £77,000 | £8,847,000 | £8,283,000 |
| Turnover | £25,854,000 | £17,598,000 | £13,587,000 |
| Cost of Sales | £16,482,000 | £11,745,000 | £8,139,000 |
| Gross Profit | £9,372,000 | £5,853,000 | £5,448,000 |
| Admin Expenses | £12,767,000 | £6,090,000 | £3,244,000 |
| Staff Costs | £5,911,000 | £3,276,000 | £1,915,000 |
| Operating Profit | (£3,665,000) | (£513,000) | £1,947,000 |
| Profit Before Tax | (£3,662,000) | £327,000 | £2,065,000 |
| Tax | (£76,000) | £95,000 | £139,000 |
| Profit for Period | (£3,586,000) | £232,000 | £1,926,000 |
Filings 224
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 4 June 2026 | Confirmation statement with updates | 3 June 2026 | ||
| 28 April 2026 | Full accounts | 31 December 2024 | ||
| 12 June 2025 | Confirmation statement with updates | 3 June 2025 | ||
| 30 May 2025 | Full accounts | 31 December 2023 | ||
| 2 May 2025 | Termination of appointment of a director |
Some other companies at this address
Other companies in this industry
Beaconsfield
Bridgend
Stratford Upon Avon
Teddington
Sunderland
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →